Cargando…
In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
Nasa P, Chaudhry D. In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity. Indian J Crit Care 2022;26(3):405.
Autores principales: | Nasa, Prashant, Chaudhry, Dhruva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015913/ https://www.ncbi.nlm.nih.gov/pubmed/35519915 http://dx.doi.org/10.5005/jp-journals-10071-24139 |
Ejemplares similares
-
Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022) -
Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19
por: Nasa, Prashant, et al.
Publicado: (2021) -
Prevention and Control of Non-Communicable Diseases in Iran: A Window of Opportunity for Policymakers
por: MOUSAVI, Seyyed Meysam, et al.
Publicado: (2014) -
The association between corticosteroid uses and mortality among severe COVID-19 patients
por: Tang, Hung-Jen, et al.
Publicado: (2021) -
Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report
por: Hu, Zhiliang, et al.
Publicado: (2020)